TrialBMC complementary medicine and therapies2020

A randomized, double-blind, positive-controlled, prospective, dose-response clinical study to evaluate the efficacy and tolerability of an aqueous extract of Terminalia bellerica in lowering uric acid and creatinine levels in chronic kidney disease subjects with hyperuricemia.

Usharani Pingali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.